NCT05184153 (MEDCCR) is a clinical trial in Medullary Carcinoma of Colon, sponsored by University Hospital, Limoges.

Who is sponsoring NCT05184153?

NCT05184153 is sponsored by University Hospital, Limoges.

What condition does NCT05184153 study?

NCT05184153 studies Medullary Carcinoma of Colon, Prognostic Factors, Survival Analysis.

Is NCT05184153 still recruiting?

NCT05184153 is currently completed. Last updated 11 January 2022.

Last reviewed 2022-01-11 · How we verify

NCT05184153: MEDCCR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medullary Colonic Carcinoma

Completed Last updated 11 January 2022

What this trial tests

trial in Medullary Carcinoma of Colon in 10 participants. Completed in 1 September 2021.

Timeline

3 March 2020

Primary endpoint
19 December 2020

1 September 2021

Quick facts

Lead sponsor	University Hospital, Limoges
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10
Start date	3 March 2020
Primary completion	19 December 2020
Estimated completion	1 September 2021
Sites	1 location across France

Conditions studied

Medullary Carcinoma of Colon — all drugs for Medullary Carcinoma of Colon →
Prognostic Factors — all drugs for Prognostic Factors →
Survival Analysis — all drugs for Survival Analysis →

Sponsor

University Hospital, Limoges

Who can join

Eligibility, any sex, with Medullary Carcinoma of Colon or Prognostic Factors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective cohort of 10 cases of colonic adenocarcinoma of medullary type, operated between 2000 and 2020 at the University Hospital of Limoges. Collection of relevant data for this rare entity. Subgroup analysis in search of prognostic factors. Comparison of the data from our cohort with those from the literature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Limoges trials

Trials by the same sponsor.

NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05184153 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
Last refreshed: 11 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05184153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing